NCT03340506 2026-02-03Dabrafenib and/or Trametinib Rollover StudyNovartisPhase 4 Recruiting100 enrolled
NCT04418167 2025-09-03JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway MutationsJS InnoPharm, LLCPhase 1 Suspended71 enrolled